EDITORIAL
Well I must admit
it has been a little hard motivating myself to start up a new year,
but once having started, the issues began to clarify and flow freely.
Pharmacy concerns seem to be hardening around some issues of globalisation
(it is quietly happening at a very rapid pace-most of us are not recognising
this fact); the issue of Guild representation and how it is only representing
a minority of the pharmacist population; the issue of corporatisation
(or the lack of it) which inhibits pharmacy as a whole, leaving it unprotected
and unable to realise its fullest business and professional potential.
How can we be ready to compete against global predators with inefficient
business structures?
Lack of a corporate pharmacy structure must also be of concern to newly
graduated pharmacists, for this is one practical method of securing
a partial ownership of a pharmacy, on a progressive basis.
It is still denied to them.
The unexpected shock
of UK pharmacists negotiating with one wing of government, suddenly
finding the skids taken out from under them by another wing, must serve
as a continuing warning to Australian pharmacists. While the system
of ownership within Australia appears stronger than the UK, pharmacists
must remain vigilant.
The Australian pharmacy model, despite all the criticisms from economic
rationalists and the like, still continues to be one of the most efficient
in the western world, particularly when compared with the American and
the British models.
Some of our writers over time have worked in both systems, and Australia
still comes up trumps!
So we need to build on our existing strengths and ensure we can become
structurally and financially stronger.
This may mean borrowing some of the better global elements to reinforce
our local offering, particularly at the pharmacy political level. The
recent attacks by American global pharmaceutical interests on our PBS,
through our bilateral trade agreements, is just one instance of a threat
never before envisaged by Australian pharmacists.
Accreditation systems
are also causing concern.
There are obvious benefits if a high standard is maintained, but it
also comes at a cost.
It would appear that some flexibility needs to be built in to the system.
I would also point
you to the press release on MediConnect (the new BMMS), because this
is going to have a profound effect on your professional and business
lives. Also, in the background are some rumblings about its high cost,
unproven benefits and the fact that it has a 90 percent chance of failing
(compared to other systems of similar size that have been attempted).
We have a new writer,
John Skyllas, who is noted for his candid point of view, and our other
writers have produced some articles of specific interest that provide
excellent reading.
Neil
Johnston
February, 2002
BACK
TO MAIN PAGE
...
|